Found 507 matching trials
Using ctDNA to Determine Therapies for Lung Cancer PHASE2 This is a study to look at whether the presence of circulating tumour DNA (...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients PHASE3 This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer PHASE1 Study to determine the best dose of stereotactic body radiation therapy (SB...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer PHASE1 This phase I trial evaluates the effects of CBM588 in combination with stan...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors PHASE1 The purpose of this study is to determine safety and effectiveness of exper...
Show More Location
Local Institution
Learn More & Join Trial
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma PHASE1 This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part.
...
Show More Location
Multiple Locations
Learn More & Join Trial
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma PHASE2 This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Show More Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Learn More & Join Trial
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma PHASE1 This phase I trial tests the safety, side effects, and best dose of nivolum...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) PHASE1 The purpose is to determine the safety, effectiveness and best dose to use ...
Show More Learn More & Join Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 This randomized phase II trial studies how well nivolumab works with or wit...
Show More Location
Sutter Auburn Faith Hospital
Learn More & Join Trial